Cargando…

The value of renal score in both determining surgical strategies and predicting complications for renal cell carcinoma: A systematic review and meta‐analysis

OBJECTIVES: Radical nephrectomy (RN) was the standard treatment for renal cell carcinoma (RCC). However, recent studies have found that partial nephrectomy (PN) could achieve similar effects as radical nephrectomy, and has the advantages of less bleeding and shorter hospital stay. The choice of surg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Naipeng, Zu, Feng, Shan, Yong, Chen, Shuqiu, Xu, Bin, Du, Mulong, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286475/ https://www.ncbi.nlm.nih.gov/pubmed/32281277 http://dx.doi.org/10.1002/cam4.2993

Ejemplares similares

Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome
por: Arai, Eri, et al.
Publicado: (2009)

Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Construction of immune‐related risk signature for renal papillary cell carcinoma
por: Wang, Zhongyu, et al.
Publicado: (2018)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

δ‐Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β‐catenin nuclear localization and activating its downstream target genes
por: Ju, Lincheng, et al.
Publicado: (2020)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
por: Hong, Andrew L, et al.
Publicado: (2019)

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
por: Xu, Jianing, et al.
Publicado: (2019)

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
por: Calcagnì, Alessia, et al.
Publicado: (2016)

Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer‐associated fibroblasts
por: Wang, Fang‐Tao, et al.
Publicado: (2021)

PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies
por: Ding, Lei, et al.
Publicado: (2021)

Hypoxia-inducible factor-2α regulates the expression of TRAIL receptor DR5 in renal cancer cells
por: Mahajan, S., et al.
Publicado: (2008)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is Planned
por: Agarwal, Dinesh K., et al.
Publicado: (2023)

Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells
por: Suzuki, Kenjiro, et al.
Publicado: (2013)

Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
por: Kitano, Hiroyuki, et al.
Publicado: (2017)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
por: Luo, Jun, et al.
Publicado: (2020)

Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma
por: Yang, Chaoxu, et al.
Publicado: (2018)

Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B
por: Liu, Junlong, et al.
Publicado: (2019)

Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells
por: Glykofridis, Iris E, et al.
Publicado: (2021)

Robot‐assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score‐based analysis
por: Deng, Wen, et al.
Publicado: (2019)

Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2019)

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
por: Liao, Lili, et al.
Publicado: (2018)

Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway
por: Jiang, Hao, et al.
Publicado: (2019)

Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation
por: Li, Yuqing, et al.
Publicado: (2020)

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
por: Eckel‐Passow, Jeanette E., et al.
Publicado: (2019)

Ubiquitin‐specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF‐κB pathway inactivation
por: Gui, Dingwen, et al.
Publicado: (2021)

Serum markers change for intraocular metastasis in renal cell carcinoma
por: Sun, Tie, et al.
Publicado: (2021)

Radiosensitizing effects of miR‐18a‐5p on lung cancer stem‐like cells via downregulating both ATM and HIF‐1α
por: Chen, Xu, et al.
Publicado: (2018)

Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β
por: Petrella, Brenda L, et al.
Publicado: (2012)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma
por: Narimatsu, Takahiro, et al.
Publicado: (2015)

Correction: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
por: Liao, Lili, et al.
Publicado: (2021)

Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
por: Liu, Qiaoling, et al.
Publicado: (2021)

The lncRNA SNHG5‐mediated miR‐205‐5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1
por: Xiang, Wei, et al.
Publicado: (2020)

Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data
por: Noureen, Nighat, et al.
Publicado: (2022)

Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy
por: Liu, Hui, et al.
Publicado: (2020)

The prognostic value of circRNAs for gastric cancer: A systematic review and meta‐analysis
por: Chen, Hui, et al.
Publicado: (2020)

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4fp4h27qr6k98lqbmfl0jjogoa